The Symptom Management Program for Dyspnea in Patients with Advanced Cancer

Development and Application of the Symptom Management Program for Dyspnea Relief in Patients with Advanced Cancer

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200060329

Enrollment

Unknown

Registered

2022-05-28

Start date

2022-05-16

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dyspnea in patients with terminal cancer

Interventions

control group:routine care

experimental group:program intervention

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Malignant tumors are diagnosed by histology or cytology, and the stage is stage III or stage IV; 3. The NRS score of dyspnea when the patient sits quietly or rests is >= 3 points, that is, there is more than mild dyspnea; 4. Peripheral blood oxygen saturation SpO2 >= 90%; 5. Clear consciousness, able to express subjective feelings in Chinese.

Exclusion criteria

Exclusion criteria: 1. Fever greater than 38°C within 24 hours; 2. Diagnosed with severe anemia or hemoglobin level <= 6 g/dL; 3. Are undergoing a disease or treatment affecting the trigeminal nerve.

Design outcomes

Primary

Measure	Time frame
dyspnea degree;life quality;	—

Secondary

Measure	Time frame
anxiety;	—

Countries

China

Contacts

Public ContactGuijuan He

Zhejiang Chinese Medical University

sheryhe@163.com+86 571 86633020

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026